JUNS Jupiter Neurosciences, Inc.
Healthcare$0.23-3.28%ClosedMarket Cap: $8.3M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
-3.01
P/S
213.30
EV/EBITDA
-1.23
DCF Value
$-0.04
FCF Yield
-67.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
89.2%
Operating Margin
-23075.8%
Net Margin
-22690.8%
ROE
1140.9%
ROA
-232.4%
ROIC
-455.4%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $18.7K | 76.6% | $-2.0M | $-2.1M | $— | — |
| Q4 null | $21.8K | 100.0% | $-2.8M | $-2.6M | $— | — |
| FY null | $21.8K | 80.6% | $-8.9M | $-8.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-2.3M | $-2.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.3M | $-2.3M | $— | — |
| Q1 null | $0.00 | NaN% | $-1.5M | $-1.5M | $— | — |
| Q4 null | $0.00 | NaN% | $-1.5M | $-1.5M | $— | — |
| FY null | $0.00 | NaN% | $-3.1M | $-2.4M | $— | — |
| Q3 null | $0.00 | NaN% | $-493.5K | $-591.0K | $— | — |
| Q2 null | $0.00 | NaN% | $-557.1K | $313.1K | $— | — |
| Q1 null | $0.00 | NaN% | $-570.7K | $-634.1K | $— | — |
| Q4 2023 | $0.00 | NaN% | $-535.6K | $-429.6K | $-0.01 | — |